相关实验视频

Updated: Jul 12, 2025

Orthotopic Transplantation of Breast Tumors as Preclinical Models for Breast Cancer

Orthotopic Transplantation of Breast Tumors as Preclinical Models for Breast Cancer

Published on: May 18, 2020

更新2023年乳腺癌第一部分 - 乳腺癌早期阶段

Andreas D Hartkopf¹, Tanja N Fehm², Manfred Welslau³

¹Department of Gynecology and Obstetrics, Ulm University Hospital, Ulm, Germany.

Geburtshilfe und Frauenheilkunde

|November 2, 2023

概括

像abemaciclib和olaparib这样的新辅助疗法正在改变早期乳腺癌的治疗. 研究正在探索用于辅助剂的已建立的转移性治疗方法,包括新型抗体-药物合物.

科学领域:

在瘤学瘤学.
临床试验临床试验
乳腺癌的治疗方法

背景情况:

早期乳腺癌的护理标准随着abemaciclib (monarchE) 和olaparib (OlympiA) 在辅助剂环境中的批准而发展.
翻译性研究正在积极将有效的转移性乳腺癌治疗方法转移到辅助环境中.

研究的目的:

审查和对乳腺癌辅助治疗的最新进展进行上下文化.
突出新兴的临床研究,调查早期疾病的已确定的转移性病原体.

主要方法:

对最近的临床试验数据和出版物的文献综述.
在辅助剂环境中对abemaciclib,olaparib,trastuzumab deruxtecan和sacituzumab govitecan的信息的综合.

主要成果:

现在,abemaciclib和olaparib已经成为特定的早期乳腺癌患者的辅助疗法.
目前正在进行的试验,如DESTINY Breast05 (trastuzumab deruxtecan) 和SASCIA (sacituzumab govitecan),正在评估有前途的药物.
纳塔利研究也报告了积极的发现,进一步扩大了治疗选择.

结论:

早期乳腺癌的辅助治疗场景正在迅速发展,新的向疗法和抗体药物合剂正在迅速发展.
对在转移性环境中成功使用的药物的持续研究对改善辅助治疗结果具有重大前景.

关键词:

辅助疗法是一种辅助疗法.生物标志物生物标志物乳腺癌乳腺癌乳腺癌在早期的早期阶段.内分泌疗法是一种内分泌疗法.新辅助疗法是一种新辅助疗法.

更多相关视频

Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model

Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model

Published on: March 20, 2020

Quantification of Breast Cancer Cell Invasiveness Using a Three-dimensional 3D Model

Quantification of Breast Cancer Cell Invasiveness Using a Three-dimensional 3D Model

Published on: June 11, 2014

相关概念视频

Tumor Progression

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...